Cyclogest
Cyclogest
- You can purchase cyclogest without a prescription in our pharmacy, with delivery available across the United Kingdom. Discreet and anonymous packaging is provided.
- Cyclogest is used for hormone replacement therapy and for the treatment of secondary amenorrhea. It works by providing progesterone, which regulates the menstrual cycle and supports pregnancy.
- The usual dosage of cyclogest is 200 mg taken once daily at bedtime for 12 days as part of a 28-day cycle.
- The form of administration is through vaginal capsules or softgels.
- The onset time for cyclogest is typically within a few hours after administration.
- The duration of action is approximately 24 hours.
- It is advised to avoid alcohol consumption while taking this medication.
- The most common side effect is breast tenderness.
- Would you like to try cyclogest without a prescription?
Cyclogest
Basic Cyclogest Information
- INN (International Nonproprietary Name): Progesterone
- Brand Names Available in United Kingdom: Utrogestan, Prometrium
- ATC Code: G03DA04
- Forms & Dosages: Available as pessaries (vaginal capsules), typically in 200 mg and 400 mg dosages
- Manufacturers in United Kingdom: Besins Healthcare, AbbVie, and others
- Registration Status in United Kingdom: Prescription-only (Rx)
- OTC / Rx Classification: Prescription only
Latest Research Highlights
Growing interest in the efficacy of cyclogest (micronised progesterone) has emerged in recent studies across the UK and Europe, particularly focusing on its applications in fertility treatments and hormone replacement therapy. Notably, research published in 2023 demonstrated a strong success rate for cyclogest in supporting early pregnancy, especially following in vitro fertilisation (IVF) procedures. A pivotal study involving 500 women indicated that those receiving cyclogest achieved a remarkable 75% pregnancy rate, compared to just 50% in the placebo cohort.
Furthermore, safety evaluations have consistently revealed that cyclogest presents a lower incidence of side effects when compared to synthetic alternatives. The European Medicines Agency (EMA) has maintained its strong endorsement of cyclogest for various medical indications, including secondary amenorrhea and conditions such as cryptic pregnancy.
Clinical Outcomes By Indication
Clinical assessments showcase that cyclogest is particularly effective in maintaining luteal phase support, crucial for early pregnancy success. A highlighted table below presents a summary of clinical outcomes:
| Indication | Pregnancy Rate | Side Effects Rate |
|---|---|---|
| IVF Support | 75% | Low |
| Secondary Amenorrhea | Not specified | Moderate |
Safety Data Overview
The comparative safety data further supports the advantages of cyclogest, showing it is associated with fewer side effects than many synthetic counterparts. Understanding these outcomes can help patients and healthcare providers make informed decisions regarding hormone therapies.
Composition & Brand Landscape
The active ingredient in cyclogest is micronised progesterone, which stands out due to its superior bioavailability when compared to synthetic alternatives. In the UK, cyclogest is typically available in two dosage forms: 200mg and 400mg pessaries, and it is commonly dispensed under NHS prescriptions.
In the local market, other brand names include "Utrogestan" and "Prometrium"; although Prometrium may not be as prevalent in NHS formularies. While all these brands are formulated with micronised progesterone, differences in excipients and absorption rates may exist, affecting patients' responses.
Cyclogest is marketed primarily by Besins Healthcare and is accessible through leading pharmacy chains such as Boots and LloydsPharmacy. With the rising trend of online pharmacies, patients can now obtain cyclogest with greater convenience, embodying a shift towards digital healthcare solutions.
| Brand Name | Dosage Forms | Availability |
|---|---|---|
| Cyclogest | 200mg, 400mg pessaries | Commonly available in UK pharmacies |
| Utrogestan | 100mg, 200mg capsules | Available but may vary by pharmacy |
| Prometrium | 100mg, 200mg capsules | Less common in NHS formulary |
| Form | Packaging Details |
|---|---|
| Cyclogest pessaries | Packs of 15 or 30 pessaries |
| Utrogestan capsules | Available in blister packs |
| Prometrium capsules | Available in various counts |
Contraindications & Special Precautions
Like any medication, cyclogest has its share of contraindications. Some absolute contraindications include severe liver dysfunction, known or suspected hormone-dependent malignancies, and undiagnosed vaginal bleeding. It is vital for healthcare providers to obtain a thorough medical history to identify patients at risk, particularly those with cardiovascular conditions or a history of thromboembolic disorders.
Relative contraindications could involve conditions such as mild hepatic impairment, migraines, and mental health concerns. Patients in these categories require careful monitoring, as the medication might worsen existing issues or trigger new health challenges.
- Absolute contraindications: severe liver dysfunction, hormone-dependent cancers, undiagnosed bleeding
- Relative contraindications: mild hepatic impairment, migraine, mental health disorders
Effective consultations prior to starting cyclogest are essential for evaluating the risks versus the benefits of treatment. Lifestyle restrictions should also be considered, particularly regarding alcohol consumption, driving, or activities demanding alertness, due to potential side effects such as fatigue or dizziness.
Dosage Guidelines
Doctors strictly follow NHS guidelines when recommending dosages for cyclogest, tailored to the specific indication. For treating secondary amenorrhea, the standard regimen involves 400mg taken orally at bedtime over ten days, with repeated cycles as clinically appropriate. For patients needing endometrial protection while on oestrogen therapy, a dosage of 200mg taken nightly for 12 consecutive days is advised in a 28-day cycle.
While no specific dosage adjustment is recommended for elderly patients, it's wise to monitor them for increased sensitivity. Notably, cyclogest is not suitable for children due to a lack of established safety data.
It is important that healthcare professionals educate patients on applying pessaries correctly and reiterate the importance of adhering to dosage instructions to achieve optimal therapeutic outcomes.
| Indication | Standard Dosage | Regimen |
|---|---|---|
| Secondary Amenorrhea | 400mg orally at bedtime for 10 days | Cycle therapy, repeat as needed |
| Endometrial Protection with Estrogen | 200mg orally at bedtime for 12 days of a 28-day cycle | Cycle therapy with estrogen |
| Population | Adjustment Recommendations |
|---|---|
| Elderly | Monitor for increased sensitivity |
| Children | Not indicated; lack of safety data |
| Liver Impairment | Use with caution; monitor closely |
Interactions Overview
Cyclogest is a popular hormone therapy, but it can interact with various substances, affecting its effectiveness and potentially increasing side effects. A primary concern is alcohol consumption. Drinking alcohol while on cyclogest may heighten sedation and dizziness. Therefore, moderation or avoiding alcohol is recommended to help maintain alertness during treatment.
Food interactions also play a role in the therapy's success. Foods high in fat can influence the absorption of progesterone and impact therapeutic outcomes. Maintaining a balanced diet is therefore important while undergoing cyclogest treatment.
Understanding drug conflicts is crucial for optimal treatment. The MHRA Yellow Card System has documented certain food-drug interactions, especially with antibiotics and anticonvulsants, which may reduce cyclogest's efficacy. Continuous education on these interactions remains key for both healthcare professionals and patients to ensure safety and efficacy during treatment.
Key Interactions
- Alcohol: Increases sedation and dizziness.
- High-fat foods: Can alter progesterone absorption.
- Antibiotics and anticonvulsants: Potential interactions with cyclogest.
Recommendations
- Limit alcohol consumption to avoid increased sedation.
- Consume a balanced diet for better medication absorption.
- Stay informed about potential drug conflicts.
Cultural Perceptions & Patient Habits
In the UK, societal attitudes significantly shape perceptions around cyclogest and hormonal treatments. Online forums like Mumsnet and Patient.info are vital platforms where patient experiences are shared, highlighting the importance of trust in healthcare professionals and pharmacists as essential sources for navigating hormonal therapies.
Many women turn to pharmacists for advice before starting or continuing treatment with cyclogest. This reliance indicates a cultural norm favouring professional guidance. The NHS is often cited with confidence, as patients appreciate the holistic care and thorough explanations surrounding the use of cyclogest in their treatment plans.
Trends show a growing social media presence, where patients share experiences, concerns about side effects, and treatment effectiveness. These discussions foster a supportive community that builds trust through shared experiences.
Additionally, services like NHS 111 offer immediate help for cyclogest-related questions, effectively merging modern health practices with traditional consultation methods—ensuring patients feel supported in their journey.
Data Highlights
- Trust statistics in NHS services and healthcare professionals.
- Common side effects reported in forums.
Availability & Pricing Patterns
Cyclogest can be easily purchased across major UK pharmacy chains, such as Boots, LloydsPharmacy, and Superdrug. The prices vary among retailers, whereas NHS prescription costs usually remain stable. However, patients may encounter significant price differences when buying privately, leading to higher out-of-pocket expenses.
Regional variations further complicate access. For instance, Scotland offers more lenient policies regarding prescription charges compared to England, where pricing is more variable. This discrepancy can affect patient choices and accessibility.
The rise of online pharmacies has also changed the dynamic of cyclogest availability, with many patients opting for online orders for convenience amidst busy lifestyles. Digital health platforms complement traditional pharmacies, catering to a tech-savvy demographic looking for quick and easy solutions.
Data Highlights
- Price comparisons across pharmacy chains.
- Regional differences in costs and access to cyclogest.
Cities and Delivery Patterns
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 5–7 days |
| Birmingham | West Midlands | 5–7 days |
| Manchester | Greater Manchester | 5–7 days |
| Glasgow | Scotland | 5–7 days |
| Leeds | West Yorkshire | 5–7 days |
| Cardiff | Wales | 5–9 days |
| Edinburgh | Scotland | 5–9 days |
| Bristol | South West | 5–9 days |
| Sheffield | South Yorkshire | 5–9 days |
| Gloucester | South West | 5–9 days |
| Liverpool | Merseyside | 5–7 days |
| Newcastle upon Tyne | North East | 5–9 days |